Megabank stocks rise in premarket as Pfizer deal boosts underwriting
Stocks for the largest U.S. banks rose in premarket trades on Wednesday, amid an uptick in underwriting activity following a $31 billion debt offering from pharmaceutical giant Pfizer Inc. (PFE). Bank of America Corp. 's (BAC) BofA Securities unit, Citigroup Inc. (C), Goldman Sachs Group Inc. (GS) and J.P. Morgan Chase & Co. (JPM) are joint lead managers and joint book-running managers for the Pfizer offering, which consisted of eight tranches priced between 4.45% and 5.34%. Bank of America stock is up 0.6%, Citigroup is up 0.7%, Goldman Sachs is up 0.5% and JPMorgan Chase is up by 0.7%.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 17, 2023 07:43 ET (11:43 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.